Product Image
Please see full prescribing and safety information, including boxed warning, for SODIUM NITROPRUSSIDE vials.

Available in:

  • 50 mg per 2 mL single-dose vials

Benefits:

  • AP Rated
  • Preservative-free
  • Not made with natural rubber latex

SODIUM NITROPRUSSIDE Injection*

Brand Name Equivalent: NITROPRESS® (NITROPRESS is a registered trademark of Hospira, Inc.)
Therapeutic Category: Cardiovascular

PreventIV MeasuresTM Features:

  • Easy-to-read drug name and dosage strength to aid in identifying the right product
  • Bar codes included on the vial and carton for ease of scanning
  • Unique label design to help products stand out on the shelf
  • Enhanced packaging and labeling designed to promote safety and help reduce the risk of medication errors
NDC
#25021
Description Strength Fill
Volume
Concentration Container
Size
Closure Unit
of Sale
310-02** Amber Glass Vial 50 mg 2 mL 25 mg per mL 2 mL 13 mm 1

** Opaque sleeve included to protect the infusion solution from light
Sodium Nitroprusside Injection is not suitable for direct injection. The solution must be further diluted in sterile 5% dextrose injection before infusion.
Sodium Nitroprusside can cause precipitous decreases in blood pressure (see DOSAGE AND ADMINISTRATION). In patients not properly monitored, these decreases can lead to irreversible ischemic injuries or death. Sodium nitroprusside should be used only when available equipment and personnel allow blood pressure to be continuously monitored.
Except when used briefly or at low (< 2 mcg/kg/min) infusion rates, sodium nitroprusside gives rise to important quantities of cyanide ion, which can reach toxic, potentially lethal levels (see WARNINGS). The usual dose rate is 0.5 to 10 mcg/kg/min, but infusion at the maximum dose rate should never last more than 10 minutes. If blood pressure has not been adequately controlled after 10 minutes of infusion at the maximum rate, administration of sodium nitroprusside should be terminated immediately.
Although acid-base balance and venous oxygen concentration should be monitored and may indicate cyanide toxicity, these laboratory tests provide imperfect guidance.